Collins Helen Louise

CIK 00017012474 companiesBOULDER, CO

SEC Profile

Transactions

Companies

Filings

CIK

0001701247

Recent Transactions

50 trades

Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2026-02-17−45,000→ 221,268 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-02-17$2.48/sh+45,000→ 70,000 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-02-17$26.17/sh−45,000→ 25,000 total
Award
Enliven Therapeutics, Inc.$ELVN
Common Stock
2026-02-12+25,000→ 25,000 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2026-02-12+150,000→ 150,000 total
Award
IO Biotech, Inc.$IOBT
Stock Option (Right to Buy)
2025-06-05+35,144→ 35,144 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2025-06-05+28,500→ 28,500 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2025-02-06+171,000→ 171,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-10-18−816→ 266,268 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-18$2.48/sh+816→ 816 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-10-18$30.00/sh−816→ 0 total
Award
IO Biotech, Inc.$IOBT
Stock Option (Right to Buy)
2024-06-06+45,642→ 45,642 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2024-06-05+26,000→ 26,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-11$2.48/sh+20,000→ 20,000 total
Exercise/Conversion
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-04-11−20,000→ 267,084 total
Sale
Enliven Therapeutics, Inc.$ELVN
Common Stock
2024-04-11$25.07/sh−20,000→ 0 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2024-02-13+185,000→ 185,000 total
Award
IO Biotech, Inc.$IOBT
Stock Option (Right to Buy)
2023-11-15+64,238→ 64,238 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2023-05-31+26,000→ 26,000 total
Award
Enliven Therapeutics, Inc.$ELVN
Stock Option (right to buy)
2023-04-04+206,000→ 206,000 total
Award
Enliven Therapeutics, Inc.$ELVN
Employee Stock Option (right to buy)
2023-02-23+287,084→ 287,084 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2022-06-21+23,000→ 23,000 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2021-07-28+19,166→ 19,166 total
Award
Kura Oncology, Inc.$KURA
Option to purchase common stock
2021-07-28+46,000→ 46,000 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2021-04-16−60,000→ 0 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2021-04-16−50,000→ 0 total
Award
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2021-04-16+66,000→ 135,547 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2021-04-16$38.00/sh−135,547→ 0 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2021-04-16−20,000→ 0 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2021-04-16−58,000→ 0 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2021-04-16−90,000→ 0 total
Disposition to Issuer
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2021-04-16−90,000→ 0 total
Gift
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2021-03-31−8,085→ 69,547 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2021-02-26$22.23/sh−1,158→ 77,632 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2021-02-25$23.08/sh−1,653→ 78,790 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2021-02-24$25.71/sh−5,091→ 80,443 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2020-12-11$16.14/sh−11,583→ 85,534 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2020-12-11+22,000→ 97,117 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Performance-Based Restricted Common Stock
2020-12-11−22,000→ 0 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2020-11-11$18.00/sh−11,039→ 75,117 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2020-11-11+22,000→ 86,156 total
Exercise/Conversion
FIVE PRIME THERAPEUTICS, INC.
Performance-Based Restricted Common Stock
2020-11-11−22,000→ 22,000 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2020-08-20$4.69/sh−827→ 64,156 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2020-03-20$2.30/sh−827→ 64,983 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2020-02-26$4.83/sh−1,281→ 65,810 total
Tax Payment
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2020-02-25$4.87/sh−1,862→ 67,091 total
Award
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2020-02-24+15,000→ 53,953 total
Award
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2020-02-24+90,000→ 90,000 total
Award
FIVE PRIME THERAPEUTICS, INC.
Common Stock
2020-02-24+15,000→ 68,953 total
Award
FIVE PRIME THERAPEUTICS, INC.
Employee Stock Option (right to buy)
2020-02-24+90,000→ 90,000 total

Companies

Recent Filings

Address

C/O ENLIVEN THERAPEUTICS, INC. 6200 LOOKOUT ROAD

BOULDER, CO, 80301

View on SEC.gov